Related Experiment Video
Updated: Dec 30, 2025

09:00
Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors
Published on: August 18, 2016
8.0K
Development of a Physiologically-Based Mathematical Model for Quantifying Nanoparticle Distribution in Tumors
Summary
This study developed a multiscale mathematical model to improve nanoparticle (NP) delivery for cancer treatment. The model predicts NP distribution in pancreatic tumors, aiding in the design of more effective nanomedicine therapies.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Mathematical Modeling
Background:
- Nanomedicine offers potential for targeted cancer drug delivery.
- Clinical translation of nanomedicine is hindered by incomplete understanding of nanoparticle behavior influenced by physiochemical and physiological factors.
Purpose of the Study:
- To develop and validate a multiscale mathematical model for assessing nanoparticle delivery efficacy in solid tumors.
- To investigate the spatiotemporal distribution of nanoparticles within pancreatic ductal adenocarcinoma (PDAC).
Main Methods:
- Integration of systemic nanoparticle disposition kinetics with NP-cell interactions within a 2D model of PDAC.
- Parameterization of the model using human physiological data from published literature.
- Verification of the multiscale approach by comparing whole-body and tissue-scale model predictions.
Main Results:
- The multiscale model accurately predicted nanoparticle concentration kinetics across different compartments.
- A higher concentration of nanoparticles was observed in the well-perfused outer tumor region compared to the necrotic inner domain.
- Model analysis confirmed the agreement between whole-body and tissue-scale predictions.
Conclusions:
- The multiscale mathematical model provides a robust framework for evaluating nanoparticle delivery to solid tumors.
- The findings highlight the importance of tumor perfusion in nanoparticle distribution.
- Further model development could optimize nanoparticle design and inform clinical interventions for cancer therapy.
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
208
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
208
Model Approaches for Pharmacokinetic Data: Physiological Models
220
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
220
Pharmacokinetic Models: Overview
1.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.8K
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
288
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
288

